Clinical trials recruiting for Healthy Participants

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
  NCT07745907 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
  NCT07463196 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL921 in Healthy Participants and Participants With Alzheimer's Disease
  NCT07758595 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
  NCT07511205 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
  NCT06980428 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 6 locations
• A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
  NCT07013643 · Phase: Phase 1 · Ages: 35 Years to 75 Years · Sex: Female · 2 locations
• A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
  NCT07723833 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
  NCT07660731 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Cognitive Strategies in Early Psychosis 1
  NCT07231497 · Phase: Phase 3 · Ages: 18 Years to 35 Years · Sex: All (male and female) · 1 location
• Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
  NCT07083089 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · 4 locations
• Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications
  NCT06097156 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
  NCT06564389 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 5 locations
• Fructose Intestinal Gluconeogenesis
  NCT07209202 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 55 Years · Sex: All (male and female) · 1 location
• IBI3042 Study in Healthy Participants and Overweight or Obese Participants
  NCT07793019 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
  NCT07095426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• OCTA in Cardiovascular Disease and Healthy Controls
  NCT07359664 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Pistachio Snacking and Metabolic Flexibility
  NCT07340125 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 45 Years · Sex: All (male and female) · 1 location
• Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
  NCT07344948 · Phase: Early Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• tVNS and Approach-Avoidance Behavior in Anhedonia and Anxiety
  NCT07476469 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Healthy Participants often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Healthy Participants trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.